当前位置:首页 - 行情中心 - 海正药业(600267) - 财务分析 - 现金流量表

海正药业

(600267)

  

流通市值:130.96亿  总市值:131.03亿
流通股本:11.98亿   总股本:11.99亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金8,563,322,286.315,791,576,436.272,722,682,572.5411,130,442,232.9
  收到的税费返还13,156,921.236,656,615.082,041,364.0427,607,365.47
  收到其他与经营活动有关的现金389,705,714.36310,601,342.47118,896,415.48355,882,736.34
  经营活动现金流入小计8,966,184,921.96,108,834,393.822,843,620,352.0611,513,932,334.71
  购买商品、接受劳务支付的现金3,882,573,352.922,541,822,928.511,432,232,724.075,206,426,097.55
  支付给职工以及为职工支付的现金1,369,853,580.84960,409,709.4584,417,014.411,619,570,942.53
  支付的各项税费602,712,320.28431,873,697210,531,098.21653,679,236.69
  支付其他与经营活动有关的现金1,466,382,116.79963,693,649.24353,732,450.381,850,162,521.39
  经营活动现金流出小计7,321,521,370.834,897,799,984.152,580,913,287.079,329,838,798.16
  经营活动产生的现金流量净额1,644,663,551.071,211,034,409.67262,707,064.992,184,093,536.55
二、投资活动产生的现金流量:
  取得投资收益收到的现金16,344,491.3311,544,400-16,975,438.36
  处置固定资产、无形资产和其他长期资产收回的现金净额3,913,015.13,410,361.323,044,406.4911,234,586.31
  收到的其他与投资活动有关的现金55,136,592.373,416,283.821,529,219.45422,180,877.59
  投资活动现金流入小计75,394,098.818,371,045.144,573,625.94450,390,902.26
  购建固定资产、无形资产和其他长期资产支付的现金215,322,290.41112,627,963.2748,824,111.48238,441,690.76
  投资支付的现金55,784,936.6530,784,936.6525,000,00039,234,450.46
  支付其他与投资活动有关的现金2,960,022.352,229,894.351,086,791.4463,075,679.98
  投资活动现金流出小计274,067,249.41145,642,794.2774,910,902.88740,751,821.2
  投资活动产生的现金流量净额-198,673,150.61-127,271,749.13-70,337,276.94-290,360,918.94
三、筹资活动产生的现金流量:
  取得借款收到的现金1,431,330,849.251,195,029,200.48569,343,2304,092,067,796
  收到其他与筹资活动有关的现金---300,000,000
  筹资活动现金流入小计1,431,330,849.251,195,029,200.48569,343,2304,392,067,796
  偿还债务支付的现金2,292,217,7961,531,217,796613,000,0004,337,170,000
  分配股利、利润或偿付利息支付的现金323,720,682.87299,991,018.8727,731,374.33148,471,078.7
  支付其他与筹资活动有关的现金59,018,938.5956,613,187.871,679,317.361,943,371,911.02
  筹资活动现金流出小计2,674,957,417.461,887,822,002.74642,410,691.696,429,012,989.72
  筹资活动产生的现金流量净额-1,243,626,568.21-692,792,802.26-73,067,461.69-2,036,945,193.72
四、汇率变动对现金及现金等价物的影响231,228.83677,653.7559,053.483,474,327.91
  现金及现金等价物净增加额平衡项目00-0.010
五、现金及现金等价物净增加额202,595,061.08391,647,512.03119,361,379.83-139,738,248.2
  加:期初现金及现金等价物余额1,189,884,406.71,189,884,406.71,189,884,406.71,329,622,654.91
  期末现金及现金等价物余额1,392,479,467.781,581,531,918.731,309,245,786.531,189,884,406.71
补充资料:
  净利润-304,913,629.54-591,311,870.59
  资产减值准备-142,462,387.53-219,020,280.63
  固定资产和投资性房地产折旧-426,759,845.36-884,578,982.87
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-426,759,845.36-884,578,982.87
  无形资产摊销-57,508,038.08-188,708,557.99
  长期待摊费用摊销-1,540,903.45-3,426,783.36
  处置固定资产、无形资产和其他长期资产的损失--305,012.36--722,661.2
  固定资产报废损失-325,243.78-1,272,666.38
  公允价值变动损失-35,878,704.73-14,926,284.66
  财务费用-53,587,757.24-151,270,555.46
  投资损失-29,880,317.54--162,959,494.8
  递延所得税-28,933,138.19-7,021,826.85
  其中:递延所得税资产减少-28,950,839.67-4,401,215.35
    递延所得税负债增加--17,701.48-2,620,611.5
  存货的减少-128,612,507.42-69,128,178.62
  经营性应收项目的减少-108,333,202.62-157,914,218.44
  经营性应付项目的增加--118,131,538.34--47,679,097.62
  其他-323,184.74-5,993,066.62
  债务转为资本---429.26
  现金的期末余额-1,581,531,918.73-1,189,884,406.7
  减:现金的期初余额-1,189,884,406.7-1,329,622,654.91
  现金及现金等价物的净增加额-391,647,512.03--139,738,248.21
公告日期2025-10-282025-08-262025-04-172025-03-29
审计意见(境内)标准无保留意见
TOP↑